Treating Patients With Prostate Cancer During COVID-19 Era Poses New Challenges
Monica L. Baskin, PhD, addresses the biggest challenges in treating patients with prostate cancer during the COVID-19 era.
Monica L. Baskin, PhD, professor, Division of Preventive Medicine, vice chair for culture and diversity, Department of Medicine, associate director, Community Outreach and Engagement, O’Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, addresses the biggest challenges in treating patients with prostate cancer during the coronavirus disease 2019 (COVID-19) era.
The biggest challenge is moving beyond the patient’s anxiety of coming into the clinic or getting involved at healthcare facilities due to concerns of COVID-19, according to Baskin. It’s important to balance these concerns with the patient’s ongoing need for treatment.
Baskin notes that many cases in prostate cancer are slow growing, in which case patients can wait for treatment. However, some patients are reluctant to complete screening and treating due to the COVID-19 pandemic. This is a challenge for many physicians, and it is important to move forward with cancer treatment and to do so in a safe manner, Baskin concludes.
Cretostimogene Grenadenorepvec Shows High CR Rate in BCG-Unresponsive NMIBC
July 17th 2024Mark D. Tyson, II, MD, MPH, discussed treatment with cretostimogene grenadenorepvec in high-risk Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer with carcinoma in situ and data from the BOND-003 trial.
Read More
Phase 3 VERIFY Trial Investigates Rusfertide’s Potential in Polycythemia Vera
July 16th 2024In an interview, Aniket Bankar, MD, discussed the background, design, and goals of the phase 3 VERIFY trial of the hepcidin mimetic rusfertide for the treatment of patients with polycythemia vera.
Read More
Examining Breast Cancer Recurrence Detection Methods in a Community Oncology Setting
July 12th 2024In an interview with Targeted Oncology, Ali Duffens, MD, discussed findings from a study which investigated detecting breast cancer recurrence among women treated at Kaiser Permanente Northern California.
Read More
